A Colorado man may have found a way to save the cannabis supplement industry from huge losses inflicted by a major pharmaceuticals company that just acquired FDA approval to sell a CBD based drug on the market.
Attorneys familiar with federal regulatory matters expect GW Pharmaceuticals to soon pressure the FDA to shut down producers of cannabidiol (CBD).
By: Jake Fogg
Video Reporter: Brian Boyd
The results of a two-year long investigation conducted by InternetDeputy.com, have been released in the embedded video report. This examination of the Cannabis industry uncovered production practices that have the potential to bring an entire industry to its knees.